| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2018/02/15 | 07:54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2018/02/15 | 04:53 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/22 | 06:26 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/21 | 20:04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/15 | 02:08 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 07:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 06:54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 06:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 06:40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 06:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00:26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00:26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00:23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00:19 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00:18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00:16 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00:13 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |